서방형 부형제 시장 규모, 점유율, 성장 분석 : 종류별, 기술별, 투여 경로별, 지역별 - 업계 예측(2026-2033년)

Sustained Release Excipients Market size was valued at USD 1.73 Billion in 2024 and is poised to grow from USD 1.87 Billion in 2025 to USD 3.49 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The sustained release excipients market represents a critical segment of the pharmaceutical industry, emphasizing the production of excipients essential for sustained release formulations. These formulations facilitate gradual drug release, enhancing patient adherence and therapeutic efficacy while minimizing dosing frequency. The market is expanding, propelled by the rising incidence of chronic diseases, the demand for innovative drug delivery systems, and the trend towards controlled-release formulations. Technological advancements in excipient development, including new polymers and coatings, enhance formulation options for manufacturers. Major players invest in R&D to innovate excipient performance and compatibility with various active pharmaceutical ingredients. Geographically, North America and Europe lead the market, with strong growth emerging in Asia-Pacific and Latin America, fueled by improved healthcare access and pharmaceutical advancements. The future outlook remains bright, driven by a focus on precision medicine and personalized therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sustained Release Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sustained Release Excipients Market Segments Analysis

Global Sustained Release Excipients Market is segmented by Type, Technology, Route of Administration and region. Based on Type, the market is segmented into Gelatin, Polymers, Minerals, Sugars and Others. Based on Technology, the market is segmented into Targeted Delivery, Microencapsulation, Wurster Technique and Others. Based on Route of Administration, the market is segmented into Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sustained Release Excipients Market

The growing elderly population is significantly influencing the sustained release excipients market, as demographic changes lead to an increased need for healthcare products and pharmaceuticals tailored to older individuals. These excipients play a crucial role by allowing extended drug release, which enhances patient compliance and effectively manages chronic health conditions. As healthcare providers respond to the unique challenges presented by an aging demographic, there is a rising demand for medications designed specifically to meet the needs of senior patients. This ongoing shift in demographics is expected to sustain a robust demand for sustained release excipients within the pharmaceutical industry.

Restraints in the Sustained Release Excipients Market

The sustained release excipients market faces significant obstacles due to stringent regulations that oversee drug approval and release processes. This complex regulatory environment presents a major hurdle for companies aiming to bring new products to market. The lengthy and costly process of securing necessary approvals while ensuring compliance with existing regulations can be challenging. Additionally, frequent changes in regulatory standards and guidelines can disrupt product development timelines and hinder market entry, ultimately impeding the growth of the market. This combination of factors makes it difficult for stakeholders to navigate the market effectively and can stifle innovation within the industry.

Market Trends of the Sustained Release Excipients Market

The sustained release excipients market is experiencing a notable trend driven by the increasing focus on personalized medicine. As the pharmaceutical industry places greater emphasis on tailoring medications to individual patient needs, innovations in sustained release excipients have become essential. These excipients allow for precise dosing and optimal release timing, enhancing therapeutic efficacy and reducing side effects. This shift towards patient-centric healthcare not only underscores the importance of customized drug delivery systems but also stimulates advancements in excipient formulations and technologies. As a result, the market is poised for robust growth, aligning with the evolving landscape of personalized therapeutic solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Sustained Release Excipients Market Size by Type & CAGR (2026-2033)

• Market Overview
• Gelatin
• Polymers
• Minerals
• Sugars
• Others

Global Sustained Release Excipients Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Targeted Delivery
• Microencapsulation
• Wurster Technique
• Others

Global Sustained Release Excipients Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Intravenous
• Others

Global Sustained Release Excipients Market Size & CAGR (2026-2033)

• North America (Type, Technology, Route of Administration)
  • US
  • Canada
• Europe (Type, Technology, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• International Flavors & Fragrances Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayne Pharma Group Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations